Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling

Bing Hu1, Einar Castillo, Louise Harewood

  • 1Department of Biochemistry, University of Lausanne, Switzerland.

Cell
|June 12, 2012
PubMed

Insights

Loss of mesenchymal Notch/CSL signaling triggers skin cancer by causing tissue changes like atrophy and inflammation. This discovery offers new insights into cancer development and potential therapeutic targets for skin tumors.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Oncology

Background:

  • The relationship between tissue changes and multifocal epithelial tumors remains unclear.
  • Investigating the role of mesenchymal signaling in tumor initiation is crucial for understanding cancer development.

Purpose of the Study:

  • To investigate whether loss of mesenchymal Notch/CSL signaling causes or results from tissue alterations preceding epithelial tumors.
  • To explore the molecular mechanisms by which CSL-deficient fibroblasts promote tumor cell proliferation.

Main Methods:

  • Utilizing genetically engineered mice with mesenchymal-specific deletion of CSL/RBP-Jκ.
  • Analyzing dermal fibroblasts from knockout mice for changes in gene expression and growth factor secretion.
  • Examining human skin samples adjacent to actinic keratosis lesions for Notch/CSL signaling alterations.
  • Investigating the effects of UVA radiation on gene expression in skin samples.

Main Results:

  • Mesenchymal-specific CSL/RBP-Jκ deletion in mice led to stromal atrophy and inflammation, preceding spontaneous multifocal keratinocyte tumors.
  • CSL-deficient dermal fibroblasts exhibited upregulated c-Jun and c-Fos, increasing tumor cell proliferation via growth factors and inflammatory cytokines.
  • Human skin adjacent to actinic keratosis showed decreased Notch/CSL signaling.
  • UVA radiation induced similar gene expression changes, linking environmental factors to these molecular alterations.

Conclusions:

  • Loss of mesenchymal Notch/CSL signaling is a potent trigger for epithelial tumors, initiating a cascade of tissue alterations.
  • CSL-deficient fibroblasts create a tumor-promoting microenvironment through molecular signaling.
  • These findings highlight the role of stromal signaling in skin cancer development and suggest potential therapeutic targets.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...